Targeting transcription factors for cancer treatment
M Lambert, S Jambon, S Depauw… - Molecules, 2018 - mdpi.com
Transcription factors are involved in a large number of human diseases such as cancers for
which they account for about 20% of all oncogenes identified so far. For long time, with the …
which they account for about 20% of all oncogenes identified so far. For long time, with the …
[HTML][HTML] Diabetes and pancreatic cancer: Exploring the two-way traffic
Pancreatic cancer (PC) is often associated with a poor prognosis. Long-standing diabetes
mellitus is considered as an important risk factor for its development. This risk can be …
mellitus is considered as an important risk factor for its development. This risk can be …
Potential role of ANGPTL4 in the cross talk between metabolism and cancer through PPAR signaling pathway
L La Paglia, A Listì, S Caruso, V Amodeo… - PPAR …, 2017 - Wiley Online Library
The angiopoietin‐like 4 (ANGPTL4) protein belongs to a superfamily of secreted proteins
structurally related to factors modulating angiogenesis known as angiopoietins. At first …
structurally related to factors modulating angiogenesis known as angiopoietins. At first …
Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting
R Pothuraju, S Rachagani, WM Junker… - Journal of Experimental …, 2018 - Springer
Background Pancreatic cancer (PC) is among foremost causes of cancer related deaths
worldwide due to generic symptoms, lack of effective screening strategies and resistance to …
worldwide due to generic symptoms, lack of effective screening strategies and resistance to …
Diabetes mellitus and obesity as risk factors for pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest types of cancer. The
worldwide estimates of its incidence and mortality in the general population are eight cases …
worldwide estimates of its incidence and mortality in the general population are eight cases …
The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity
Peroxisome proliferator-activated receptor γ (PPARγ) belongs to the nuclear receptor
superfamily of PPARs (PPARα, PPARβ/δ, PPARγ). Numerous studies have concentrated on …
superfamily of PPARs (PPARα, PPARβ/δ, PPARγ). Numerous studies have concentrated on …
Pleiotropic actions of peroxisome proliferator-activated receptors (PPARs) in dysregulated metabolic homeostasis, inflammation and cancer: current evidence and …
Background: Peroxisome proliferator-activated receptors (PPARs) have demonstrated a lot
of important effects in the regulation of glucose and lipid metabolism and in the correct …
of important effects in the regulation of glucose and lipid metabolism and in the correct …
Linking bisphenol S to adverse outcome pathways using a combined text mining and systems biology approach
JC Carvaillo, R Barouki, X Coumoul… - Environmental health …, 2019 - ehp.niehs.nih.gov
Background: Available toxicity data can be optimally interpreted if they are integrated using
computational approaches such as systems biology modeling. Such approaches are …
computational approaches such as systems biology modeling. Such approaches are …
Peroxisome proliferator‐activated receptor modulation during metabolic diseases and cancers: master and minions
The prevalence of obesity and metabolic diseases (such as type 2 diabetes mellitus,
dyslipidaemia, and cardiovascular diseases) has increased in the last decade, in both …
dyslipidaemia, and cardiovascular diseases) has increased in the last decade, in both …
Cannabinoids and PPAR ligands: the future in treatment of polycystic ovary syndrome women with obesity and reduced fertility
P Przybycień, D Gąsior-Perczak, W Placha - Cells, 2022 - mdpi.com
Cannabinoids (CBs) are used to treat chronic pain, chemotherapy-induced nausea and
vomiting, and multiple sclerosis spasticity. Recently, the medicinal use of CBs has attracted …
vomiting, and multiple sclerosis spasticity. Recently, the medicinal use of CBs has attracted …